HARP

COM:HARPOONTX

Harpoon Therapeutics, Inc.

  • Stock

USD

Last Close

22.99

08/03 21:00

Market Cap

865.08M

Beta: -

Volume Today

6.40M

Avg: -

Company Overview

Metric
Company NameHarpoon Therapeutics, Inc.
SymbolHARP
MSH IDCOM:HARPOONTX
MarketSTOCKS
SectorHealthcare
IndustryBiotechnology
CountryUS
StagePost-IPO Equity
Employee Count45
Websiteharpoontx.com
LinkedInharpoon-therapeutics
Founders

Market Metrics

Metric
Market Cap865.08M
Enterprise Value
Monthly Web Traffic2.24K
Web Traffic Growth-0.94
Valuation
Raised Capital100M

Financial Performance

Metric
Revenue31.91M
Revenue (LTM)
Revenue (NTM)
Gross Profit31.91M
EBITDA-68.33M
Operating Income-68.33M
Net Income-67.14M
EPS-2.02
Diluted EPS-2.02
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Growth Metrics

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Profitability Ratios

Metric
Gross Profit Margin0.92
Operating Profit Margin-1.05
EBITDA Margin-2.14
Net Profit Margin-0.83
Return on Equity-9.04
Return on Assets-0.65
Return on Capital Employed-1.33

Valuation Multiples

Metric
P/E Ratio-14.03
P/B Ratio1.15K
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio23.17
EV Multiple-23.68

Operational Metrics

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle-444.76
Asset Turnover0.78

Cash Flow Metrics

Metric
Operating Cash Flow-89.18M
Free Cash Flow-89.53M
Cash Flow to Debt-4.78
Operating Cash Flow/Sales-1.86
Free Cash Flow Yield-0.10

Balance Sheet Metrics

Metric
Cash & Equivalents51.61M
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization0.76
Debt to Assets0.19
Current Ratio1.45
Quick Ratio1.75

Efficiency Metrics

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue0.20
R&D to Revenue2.19
SG&A to Revenue0.51